Valuation Freenome, Inc.

Stocks

End-of-day quote Nasdaq 2026-08-14			5-day change	1st Jan Change
11.56 ^USD	-0.43%		-0.52%	-11.28%

06:20am	TD Cowen Initiates Freenome at Buy With $17 Price Target	MT
08-17	Sector Update: Healthcare Stocks Softer Late Afternoon	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2026	2027	2028
Market Cap ¹	1,467	-	-
Change	-	-	-
Enterprise Value (EV)	1,467	1,467	1,467
Change	-	0%	0%
P/E	-2.02x	-4.45x	-3.53x
PBR	-	-	-
PEG	-	0.1x	-0.1x
Capitalization / Revenue	179x	10.8x	13.1x
EV / Revenue	179x	10.8x	13.1x
EV / EBITDA	-6.24x	-5.45x	-4.04x
EV / EBIT	-5.48x	-4.99x	-3.77x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-6.44	-2.92	-3.68
Distribution rate	-	-	-
Net sales ¹	8.2	136.4	111.7
EBITDA ¹	-235	-269	-363
EBIT ¹	-267.5	-294.1	-389
Net income ¹	-291.2	-324.3	-425.8
Net Debt	-	-	-
Reference price ²	13.00	13.00	13.00
Nbr of stocks (in thousands)	112,858	-	-
Announcement Date	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
FREENOME, INC.	-	-	-	-	1.47B
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-45.48x	13.07x	840.69x	-.--%	3.95B
VERACYTE, INC.	37.96x	4.81x	17.64x	-.--%	3.38B
IOVANCE BIOTHERAPEUTICS, INC.	-14.67x	7.61x	-13.81x	-.--%	3.22B
CAREDX, INC.	21.71x	-	-	-	2.4B
SEEGENE, INC.	16.56x	2.03x	7.11x	3.58%	1.04B
MARAVAI LIFESCIENCES HOLDINGS, INC.	-18.47x	4.23x	26.47x	-.--%	846M
Average	-0.40x	6.35x	175.62x	0.72%	2.33B
Weighted average by Cap.	-3.03x	7.89x	270.90x	0.3%